trending Market Intelligence /marketintelligence/en/news-insights/trending/evjeyp7oflpsrjezmiu7_g2 content esgSubNav
In This List

Matinas BioPharma names chief development officer

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


Matinas BioPharma names chief development officer

Matinas BioPharma Holdings Inc., a Bedminster, N.J.-based biopharmaceutical company, appointed Theresa Matkovits as its chief development officer.

Matkovits most recently served as the COO of ContraVir Pharmaceuticals Inc., a biopharmaceutical company focusing on the development of antiviral drugs.